Will Moderna's stock price (MRNA) close above $120 per share on at le…

Market overview

The headline indicates 'exciting for investors,' implying a potential for stock growth if the cancer shot progresses positively. However, the 'inconclusive for patients' part suggests significant hurdles remain, which could temper investor enthusiasm or lead to volatility. This probability reflects a moderate optimism for a short-term price bump.

Economics prediction market

Implied probability (Yes)

55%

Closes

2026-11-17

More Economics markets

• OPEC partnership or acquisition announced? — 32% Yes
• Will Logistics Automation stock price increase by November 2026? — 59% Yes
• Grammy Awards partnership or acquisition announced? — 58% Yes
• Will IPO Market stock price increase by September 2026? — 46% Yes
• Will Interest Rates stock price increase by April 2027? — 41% Yes
• Chainsaw Man partnership or acquisition announced? — 74% Yes
• Fusion Energy partnership or acquisition announced? — 55% Yes
• Will Doja Cat stock price increase by November 2026? — 66% Yes

Browse all Economics markets →